Sumitomo Mitsui Trust Holdings »

Catalyst Pharmaceutical Partners shares owned by Sumitomo Mitsui Trust Holdings

Quarter-by-quarter ownership of Catalyst Pharmaceutical Partners (CPRX) shares owned by Sumitomo Mitsui Trust Holdings from 13F filings

Historical chart of Sumitomo Mitsui Trust Holdings investment in Catalyst Pharmaceutical Partners

Tip: Access up to 7 years of quarterly data

All positions including Catalyst Pharmaceutical Partners held by Sumitomo Mitsui Trust Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Catalyst Pharmaceutical Partners by Sumitomo Mitsui Trust Holdings

Quarter filed Position value Share count Share price at filing
2024-03-31 $426k 27k 15.94

More positions owned by Sumitomo Mitsui Trust Holdings

Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Facebook Inc cl a (META)
Alphabet Inc Class A cs (GOOGL)
Alphabet Inc Class C cs (GOOG)
Tesla Motors (TSLA)
Broadcom (AVGO)
Eli Lilly & Co. (LLY)
JPMorgan Chase & Co. (JPM)
UnitedHealth (UNH)
Berkshire Hathaway (BRK.B)
Exxon Mobil Corporation (XOM)
Visa (V)

View all positions for Sumitomo Mitsui Trust Holdings

Top funds holding Catalyst Pharmaceutical Partners

BlackRock
Deerfield Management Company
Vanguard Group
Dimensional Fund Advisors
Henderson Group
Geode Capital Management
Royce & Associates
Morgan Stanley
Marshall Wace
Robeco Investment Management
Northern Trust
Jacobs Levy Equity Management
T. Rowe Price Associates
Citadel Advisors
Voloridge Investment Management

View all funds holding Catalyst Pharmaceutical Partners